Clinical Trial Update: Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of paclitaxel liposome delivered via arterial infusion combined with systemic therapy as a second-li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Paclitaxel liposome (liposomal paclitaxel)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING